Cancer nanomedicine: is targeting our target?

Abstract
Nanomedicine may have a delivery problem. Rigorous, realistic and holistic rethinking is needed to improve nanomedicine performance and increase patient benefit. Nanomedicine may have a delivery problem. Rigorous, realistic and holistic rethinking is needed to improve nanomedicine performance and increase patient benefit in cancer therapy.

This publication has 5 references indexed in Scilit: